会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Porous Polymeric Articles
    • 多孔聚合物
    • US20110129924A1
    • 2011-06-02
    • US12308960
    • 2006-09-12
    • Jackie Y. YingEdwin Pei Yong ChowJeremy Ming Hock LohKarl Schumacher
    • Jackie Y. YingEdwin Pei Yong ChowJeremy Ming Hock LohKarl Schumacher
    • C12N5/071
    • A61L27/56B33Y80/00
    • Porous polymeric articles, and more specifically, porous polymeric articles for tissue engineering and organ replacement, are described. In some embodiments, methods described herein include use of a polymer-solvent system (e.g., phase inversion) to generate porosity in a structure. The process may include formation of a structure precursor material including a first crosslinkable component and a second component that can be precipitated in a precipitation medium. The structure precursor material may be shaped into a three-dimensional shape by a suitable technique such as three-dimensional printing. Upon shaping of the structure precursor material, at least a portion of the first component may be crosslinked. The structure may then be contacted with a precipitation medium to remove the precursor solvent from the structure, which can cause the second polymer component to precipitate and form a porous structure containing a network of uniform pores. In some embodiments, the porous structure is constructed and arranged for use as a template for ultrafiltration, cell growth, and/or for forming complex, biomimetic, porous biohybrid organs, where living cells can be immobilized and perform their normal physiological functions.
    • 描述了多孔聚合物制品,更具体地说,用于组织工程和器官置换的多孔聚合物制品。 在一些实施方案中,本文所述的方法包括使用聚合物 - 溶剂体系(例如相转化)以在结构中产生孔隙。 该方法可以包括形成包含可在沉淀介质中沉淀的第一可交联组分和第二组分的结构前体材料。 结构前体材料可以通过诸如三维印刷之类的合适技术成形为三维形状。 在结构前体材料成型时,第一组分的至少一部分可以是交联的。 然后可以将结构与沉淀介质接触以从结构中除去前体溶剂,这可使第二聚合物组分沉淀并形成含有均匀孔网络的多孔结构。 在一些实施方案中,多孔结构被构造和布置为用作超滤,细胞生长和/或形成复合物,仿生性,多孔生物杂交器官的模板,其中活细胞可被固定并执行其正常的生理功能。
    • 7. 发明申请
    • POROUS POLYMERIC MATERIAL WITH CROSS-LINKABLE WETTING AGENT
    • 具有交联润湿剂的多孔聚合材料
    • US20100048755A1
    • 2010-02-25
    • US12515264
    • 2007-11-17
    • Edwin Pei Yong ChowJackie Y. Ying
    • Edwin Pei Yong ChowJackie Y. Ying
    • C08G63/00C08J9/00C08G73/06
    • C08J9/283A61F9/0008A61L27/16A61L27/50A61L27/56C08B37/0021C08B37/0072C08F290/10C08J2207/10C08J2333/06C08L51/02G02B1/043C08L2666/02
    • A porous material is provided which comprises a transparent polymer matrix defining interconnected pores and a wetting agent. At least a portion of the wetting agent is cross-linked with the polymer matrix. A process for forming a porous polymeric material is also provided. A bicontinuous microemulsion comprising water, a wetting agent, a monomer, and a surfactant copolymerizable with the monomer is polymerized, to form a polymer defining interconnected pores. The wetting agent comprises a cross-linkable wetting agent such that after polymerization, at least a portion of the cross-linkable wetting agent is cross-linked with the polymer. The wetting agent may comprise acrylated hyaluronic acid (AHA) such as methacrylated hyaluronic acid (MeHA). The wetting agent may also comprise a hyaluronic acid (HA). The wetting agent may include an unbonded portion that this releasable from the material. A contact lens may be made from the porous material.
    • 提供一种多孔材料,其包括限定互连孔的透明聚合物基质和润湿剂。 润湿剂的至少一部分与聚合物基质交联。 还提供了一种形成多孔聚合物材料的方法。 将包含水,润湿剂,单体和可与单体共聚的表面活性剂的双连续微乳液聚合,形成限定互连孔的聚合物。 润湿剂包括可交联的润湿剂,使得在聚合后,至少一部分可交联润湿剂与聚合物交联。 润湿剂可以包括丙烯酸酯化透明质酸(AHA),例如甲基丙烯酸酯化透明质酸(MeHA)。 润湿剂还可以包含透明质酸(HA)。 润湿剂可以包括可从材料中释放的未粘合部分。 隐形眼镜可以由多孔材料制成。
    • 9. 发明申请
    • DELIVERY OF BMP-7 AND METHODS OF USE THEREOF
    • BMP-7的递送及其使用方法
    • US20120202741A1
    • 2012-08-09
    • US13500563
    • 2010-10-06
    • Daniele ZinkJackie Y. YingEdwin Pei Yong ChowFarah Tasnim
    • Daniele ZinkJackie Y. YingEdwin Pei Yong ChowFarah Tasnim
    • A61K38/18C12M3/00A61M1/14C12M3/06B01D63/02B01D61/24C12N5/071C12N5/10
    • A61K38/1875A61M1/3489C12N5/0686C12N2501/155
    • The present invention generally relates to delivery of BMP-7 or functional variants or functional fragments thereof and/or a BMP-7 agonist and methods of use thereof. In some embodiments, methods and devices are provided for delivery of BMP-7 or functional variants or functional fragments thereof and/or a BMP-7 agonist to a patient. In some cases, the BMP-7 or functional variants or functional fragments thereof and/or a BMP-7 agonist may be released in controlled fashion from a device in fluid communication with a patient. In some embodiments, the BMP-7 or functional variants or functional fragments thereof and/or a BMP-7 agonist may be expressed by cells within a device. In other embodiments, methods are provided for improving the function of devices containing renal proximal tubule cells. For example, in some embodiments, exposure of renal proximal tubule cells to BMP-7 or functional variants or functional fragments thereof and/or a BMP-7 agonist may be used to inhibit disruption of cell layers comprising renal proximal tubule cells. In another embodiment, exposure of renal proximal tubule cells to BMP-7 or functional variants or functional fragments thereof and/or a BMP-7 agonist may be used to inhibit trans- and de-differentiation of renal proximal tubule cells. In another embodiment, exposure of renal proximal tubule cells to BMP-7 or functional variants or functional fragments thereof and/or a BMP-7 agonist may be used to improve renal proximal tubule cell functions.
    • 本发明一般涉及BMP-7或功能变体或其功能片段和/或BMP-7激动剂的递送及其使用方法。 在一些实施方案中,提供方法和装置用于向患者递送BMP-7或功能变体或其功能性片段和/或BMP-7激动剂。 在一些情况下,BMP-7或其功能变体或功能片段和/或BMP-7激动剂可以以受控的方式从与患者流体连通的装置释放。 在一些实施方案中,BMP-7或其功能变体或功能片段和/或BMP-7激动剂可以由器件内的细胞表达。 在其他实施方案中,提供了用于改善含有肾近端小管细胞的装置功能的方法。 例如,在一些实施方案中,肾近端小管细胞暴露于BMP-7或功能变体或其功能性片段和/或BMP-7激动剂可用于抑制包含肾近端小管细胞的细胞层的破坏。 在另一个实施方案中,肾近端小管细胞暴露于BMP-7或功能变体或其功能片段和/或BMP-7激动剂可用于抑制肾近端小管细胞的反式和去分化。 在另一个实施方案中,肾近端小管细胞暴露于BMP-7或功能变体或其功能片段和/或BMP-7激动剂可用于改善肾近端小管细胞功能。